Consequently, our research demonstrated that the different outcomes between two types of osteoporosis in mice caused by inhibiting GLS via CB-839 were tightly connected to the suppressive effects on both aging-impaired osteoblastogenesis and OVX-enhanced osteoclastogenesis mediated by different metabolic processes downstream of glutaminolysis. Here, GLS is linked to osteoporosis.